China’s Monkeypox Shot Will Target the Actual Virus

China has started work on a monkeypox vaccine using virus taken directly from a patient, marking a departure from the western approach of repurposing an existing shot as it seeks to counter incursions from elsewhere in the world.

China National Biotec Group, a vaccine-making subsidiary of the state-owned pharmaceutical company Sinopharm, said it successfully isolated the monkeypox virus and started developing vaccines and drugs that target the pathogen.